Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality‐of‐life assessments

By  

CANCER, Vol. 120, Iss. 17, 2014-09 ,pp. : 2694-2703

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-11 ,pp. : 627-632

Karger

Access to resources Recommend Favorite

Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units

By Hagihara Mao   Kasai Hidefumi   Umemura Takumi   Kato Takahiro   Hasegawa Takaaki   Mikamo Hiroshige  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 2, 2011-04 ,pp. : 224-230

Springer Publishing Company

Access to resources Recommend Favorite

An Open-Label Safety Study of First-Line Bevacizumab in Combination with Standard Chemotherapy in Chinese Patients with Metastatic Colorectal Cancer Treated in an Expanded Access Program in Taiwan

By  

Oncology, Vol. 84, Iss. 5, 2013-03 ,pp. : 299-304

Karger

Access to resources Recommend Favorite

Safety, Pharmacokinetic, Immunogenicity, and Pharmacodynamic Responses in Healthy Volunteers Following a Single Intravenous Injection of Purified Staphylococcal Protein A

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 53, Iss. 9, 2013-09 ,pp. : 909-918

John Wiley & Sons Inc

Access to resources Recommend Favorite